Single, double and triple knockout mutants for DHAR have been reported (Noshi et al
Decreased Stroke Risk: Users have experienced a 7% reduction in stroke risk
Liraglutide and semaglutide: pooled post-hoc analysis to evaluate risk of dementia in patients with type 2 diabetes
FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means An FDA advisory committee voted on July 23, 2026 to recommend easing restrictions on four peptides BPC-157, KPV, TB-500, and MOTS-c
added peptides help boost the skin's melanin levels while activating + accelerating the natural tanning process
Always consult a licensed medical provider